GK
GKOS
GLAUKOS Corp
$139.68
-2.88%
$8.4B
No data for this timeframe.
Vol
Market Cap$8.4B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (86%)
Inst. Holders8 funds
Inst. Value$977.6M
Inst. Activity4 buys / 2 sells
Insider Activity0B / 10S
Insider Net $-$6.5M
SEC Reports4
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001192448·Prev Close $143.82
Recent Activity
May 14, 2026
Insider
Kliman Gilbert H sold 5,000 shares
Director @ $24.69 ($123.5K)
May 14, 2026
Insider
Kliman Gilbert H sold 5,000 shares
Director @ $140.76 ($703.8K)
May 14, 2026
Insider
Kliman Gilbert H sold 5,000 shares
Director @ $24.69 ($123.5K)
May 4, 2026
SEC
Two insiders at Glaukos sold shares totaling $3.05M, representing 0.037% of market cap. President & COO Gilliam sold $2.
CLUSTER — Impact 2/10
May 4, 2026
SEC
Glaukos Corp filed an 8-K attaching its May 2026 investor presentation, which reiterates financial highlights including
8-K — Impact 2/10
Mar 26, 2026
SEC
GLAUKOS Corp's President and COO, Joseph E. Gilliam, surrendered a total of 7,730 shares in two separate tax withholding
CLUSTER — Impact 3/10
Inst.
MORGAN STANLEY — ADD
670,778 shares ($75.7M)
Inst.
NORGES BANK — NEW
536,143 shares ($60.5M)
Price Targets
$151.08
+8.2% upside
Buy
Current $139.68
Low $136.00
Median $149.00
High $170.00
12 analysts
$136.00
$170.00
Analyst Ratings
8Strong Buy
11Buy
2Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 21, 2026 | BTIG | MAINTAIN | Buy → Buy |
| May 20, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Apr 30, 2026 | JP Morgan | MAINTAIN | Overweight → Overweight |
| Apr 30, 2026 | Citigroup | MAINTAIN | Buy → Buy |
| Apr 30, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.21 ▼ -1.4% | $-0.31 — $-0.10 | 11% YoY | 13 |
| Next Q | $-0.13 ▼ -39.1% | $-0.21 — $-0.04 | 17% YoY | 13 |
| Current FY | $-0.51 ▲ +5.5% | $-0.72 — $-0.34 | 43% YoY | 13 |
| Next FY | $0.48 ▲ +10.8% | $0.03 — $0.75 | 193% YoY | 12 |
Latest Reports
NEUTRAL
CLUSTER
2/10
Two insiders at Glaukos sold shares totaling $3.05M, representing 0.037% of market cap. President & COO Gilliam sold $2.
May 4, 2026
NEUTRAL
8-K
2/10
Glaukos Corp filed an 8-K attaching its May 2026 investor presentation, which reiterates financial highlights including
May 4, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $679.8M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $80.6M | NEW |
| MORGAN STANLEY | $75.7M | ADD |
| BANK OF AMERICA CORP | $60.8M | ADD |
| NORGES BANK | $60.5M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 14, 2026 | Kliman Gilbert | M | $123.5K |
| May 14, 2026 | Kliman Gilbert | SELL | $703.8K |
| May 14, 2026 | Kliman Gilbert | M | $123.5K |
| May 11, 2026 | Kliman Gilbert | M | $123.5K |
| May 11, 2026 | Kliman Gilbert | SELL | $675.0K |
8 institutional holders with $977.6M total value (8,658,026 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 4 institutions added/increased vs 2 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 6,020,492 | $679.8M | 69.5% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 714,026 | $80.6M | 8.2% | NEW |
| 3 | MORGAN STANLEY | 670,778 | $75.7M | 7.7% | ADD +56.1% |
| 4 | BANK OF AMERICA CORP /DE/ | 538,678 | $60.8M | 6.2% | ADD +66.3% |
| 5 | NORGES BANK | 536,143 | $60.5M | 6.2% | NEW |
| 6 | TWO SIGMA INVESTMENTS, LP | 98,651 | $11.1M | 1.1% | ADD +47.4% |
| 7 | WELLS FARGO & COMPANY/MN | 69,175 | $7.8M | 0.8% | ADD +69.5% |
| 8 | FMR LLC | 10,083 | $1.1M | 0.1% | NEAR_EXIT -91.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 429,578 | 670,778 | +56.1% | $75.7M | 2025-Q4 |
| NORGES BANK | NEW | — | 536,143 | — | $60.5M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 66,939 | 98,651 | +47.4% | $11.1M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 40,808 | 69,175 | +69.5% | $7.8M | 2025-Q4 |
| FMR LLC | NEAR_EXIT | 121,406 | 10,083 | -91.7% | $1.1M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 57,892 | 0 | -100.0% | $0.00 | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 285,646 | 474,930 | +66.3% | $38.7M | 2025-Q3 |
| UBS Group AG | ADD | 160,440 | 210,093 | +30.9% | $17.1M | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 6,336,619 | 121,406 | -98.1% | $9.9M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 66,939 | — | $5.5M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 57,892 | — | $4.7M | 2025-Q3 |
| NORGES BANK | EXIT | 738,828 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 738,828 | — | $76.3M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 212,246 | 285,646 | +34.6% | $29.5M | 2025-Q2 |
| UBS Group AG | DOUBLED | 78,356 | 160,440 | +104.8% | $16.6M | 2025-Q2 |
| CITADEL ADVISORS LLC | TRIM | 1,241,939 | 510,296 | -58.9% | $50.2M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | TRIM | 67,612 | 35,283 | -47.8% | $3.5M | 2025-Q1 |
| NORGES BANK | EXIT | 563,493 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 49,600 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 407,147 | 1,241,939 | +205.0% | $186.2M | 2024-Q4 |
| MORGAN STANLEY | TRIM | 662,501 | 494,685 | -25.3% | $74.2M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 25,120 | 67,612 | +169.2% | $10.1M | 2024-Q4 |
| UBS Group AG | DOUBLED | 24,806 | 63,003 | +154.0% | $9.4M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 37,992 | 49,600 | +30.6% | $7.4M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 641,761 | — | $83.6M | 2024-Q3 |
7 unique insiders with 10 transactions. Net insider value: -$6.5M ($0.00 bought, $6.5M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Kliman Gilbert H | Director | M | 5,000 | $24.69 | $123.5K |
| May 14, 2026 | Kliman Gilbert H | Director | SELL | 5,000 | $140.76 | $703.8K |
| May 14, 2026 | Kliman Gilbert H | Director | M | 5,000 | $24.69 | $123.5K |
| May 11, 2026 | Kliman Gilbert H | Director | M | 5,000 | $24.69 | $123.5K |
| May 11, 2026 | Kliman Gilbert H | Director | SELL | 5,000 | $135.00 | $675.0K |
| May 11, 2026 | Kliman Gilbert H | Director | M | 5,000 | $24.69 | $123.5K |
| May 1, 2026 | WEN LEANA | Director | SELL | 1,700 | $143.35 | $243.7K |
| May 1, 2026 | Gilliam Joseph E | PRESIDENT & COO | SELL | 19,573 | $143.54 | $2.8M |
| Apr 30, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | M | 10,000 | $38.68 | $386.8K |
| Apr 30, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | SELL | 10,000 | $140.00 | $1.4M |
| Apr 30, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | M | 10,000 | $38.68 | $386.8K |
| Apr 10, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | SELL | 1,237 | $116.72 | $144.4K |
| Apr 2, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 1,146 | $109.60 | $125.6K |
| Apr 2, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | F | 1,589 | $109.60 | $174.2K |
| Apr 2, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 3,169 | $109.60 | $347.3K |
| Apr 2, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 2,469 | $109.60 | $270.6K |
| Apr 1, 2026 | Burns Thomas William | CHAIRMAN & CEO | G | 180,308 | $0.00 | $0.00 |
| Mar 31, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 5,798 | $109.60 | $635.5K |
| Mar 25, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | A | 4,622 | $0.00 | $0.00 |
| Mar 25, 2026 | Gilliam Joseph E | PRESIDENT & COO | A | 5,829 | $0.00 | $0.00 |
| Mar 25, 2026 | Gilliam Joseph E | PRESIDENT & COO | A | 16,462 | $0.00 | $0.00 |
| Mar 25, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | SELL | 2,511 | $106.46 | $267.3K |
| Mar 25, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | A | 3,303 | $0.00 | $0.00 |
| Mar 25, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | A | 8,228 | $0.00 | $0.00 |
| Mar 25, 2026 | Burns Thomas William | CHAIRMAN & CEO | A | 9,380 | $0.00 | $0.00 |
| Mar 25, 2026 | Burns Thomas William | CHAIRMAN & CEO | A | 18,933 | $18,933.00 | $358.5M |
| Mar 24, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 4,926 | $105.23 | $518.4K |
| Mar 24, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 2,744 | $105.23 | $288.8K |
| Mar 24, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 2,546 | $105.23 | $267.9K |
| Mar 24, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | F | 2,020 | $105.23 | $212.6K |
| Mar 24, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | SELL | 1,521 | $105.24 | $160.1K |
| Mar 23, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 2,804 | $106.84 | $299.6K |
| Mar 23, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 2,628 | $106.84 | $280.8K |
| Mar 23, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | F | 1,230 | $106.84 | $131.4K |
| Mar 17, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | SELL | 625 | $99.15 | $62.0K |
| Mar 16, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 2,801 | $98.94 | $277.1K |
| Mar 16, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 1,189 | $98.94 | $117.6K |
| Mar 16, 2026 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | F | 614 | $98.94 | $60.7K |
| Mar 16, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 958 | $98.94 | $94.8K |
| Mar 16, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | SELL | 460 | $97.33 | $44.8K |
| Mar 13, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 5,212 | $97.02 | $505.7K |
| Mar 13, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 1,074 | $97.02 | $104.2K |
| Mar 13, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 2,462 | $97.02 | $238.9K |
| Mar 5, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 361 | $112.10 | $40.5K |
| Mar 5, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 1,098 | $112.10 | $123.1K |
| Feb 24, 2026 | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | F | 396 | $119.17 | $47.2K |
| Feb 24, 2026 | Gilliam Joseph E | PRESIDENT & COO | F | 1,057 | $119.17 | $126.0K |
| Feb 24, 2026 | Burns Thomas William | CHAIRMAN & CEO | F | 4,059 | $119.17 | $483.7K |
| Feb 19, 2026 | WEISNER AIMEE S | Director | G | 980 | $0.00 | $0.00 |
| Feb 19, 2026 | WEISNER AIMEE S | Director | M | 15,000 | $24.69 | $370.4K |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 2.5/10.
NEUTRAL
CLUSTER
2/10
Two insiders at Glaukos sold shares totaling $3.05M, representing 0.037% of market cap. President &
May 4, 2026
NEUTRAL
8-K
2/10
Glaukos Corp filed an 8-K attaching its May 2026 investor presentation, which reiterates financial h
May 4, 2026
NEUTRAL
CLUSTER
3/10
GLAUKOS Corp's President and COO, Joseph E. Gilliam, surrendered a total of 7,730 shares in two sepa
Mar 26, 2026
NEUTRAL
CLUSTER
3/10
Multiple GLAUKOS executives, including the CEO, CFO, and COO, sold shares in a recent cluster, but t
Mar 19, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (86% buy). Based on 22 analysts: 8 strong buy, 11 buy, 2 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$151.08 mean target
+8.2% upside
Buy (1.23)
$136.00 Low
$170.00 High
| Metric | Value |
|---|---|
| Current Price | $139.68 |
| Target Low | $136.00 |
| Target Mean | $151.08 |
| Target Median | $149.00 |
| Target High | $170.00 |
| # Analysts | 12 |
| Recommendation | Buy (1.23) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.21 | $-0.31 | $-0.10 | 11.2% | -1.4% | 0↑ 1↓ | $0.2B | 21.7% | 13 |
| Next Q 2026-09-30 |
$-0.13 | $-0.21 | $-0.04 | 17.1% | -39.1% | — | $0.2B | 16.9% | 13 |
| Current FY 2026-12-31 |
$-0.51 | $-0.72 | $-0.34 | 42.9% | +5.5% | 2↑ 0↓ | $0.6B | 24.3% | 13 |
| Next FY 2027-12-31 |
$0.48 | $0.03 | $0.75 | 193.2% | +10.8% | 2↑ 1↓ | $0.8B | 26.2% | 12 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.213 | |
| 7d ago | $-0.213 | |
| 30d ago | $-0.210 | -0.003 |
| 60d ago | $-0.212 | -0.001 |
| 90d ago | $-0.134 | -0.079 |
9 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 21, 2026 | BTIG | MAINTAIN | Buy | Buy |
| May 20, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 30, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Apr 30, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Apr 30, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 30, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 30, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 18, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 18, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 18, 2026 | BTIG | REITERATE | Buy | Buy |
| Jan 28, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 22, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Jan 14, 2026 | Needham | REITERATE | Buy | Buy |
| Jan 2, 2026 | Stephens & Co. | MAINTAIN | Overweight | Overweight |
| Jan 2, 2026 | BTIG | REITERATE | Buy | Buy |
| Dec 23, 2025 | UBS | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Buy | Buy |
| Dec 11, 2025 | Citigroup | MAINTAIN | Buy | Buy |
| Dec 9, 2025 | Needham | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 8 | 11 | 2 | 1 | 0 | 86% | |
| Apr 1, 2026 | 8 | 11 | 2 | 1 | 0 | 86% | |
| Mar 1, 2026 | 8 | 11 | 2 | 1 | 0 | 86% | |
| Feb 1, 2026 | 8 | 11 | 2 | 1 | 0 | 86% | |
| Jan 1, 2026 | 8 | 11 | 2 | 1 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 30, 2026
short_volume
Short Volume: GKOS — 56.7% short (0.7M / 1.2M)
Short: 682,120 | Exempt: 0 | TRF Vol: 1,202,339 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
GKOS Q1 2026 Earnings Scheduled — 2026-04-29
Apr 13, 2026
short_interest
FTD: GKOS — 8,538 shares ($1.0M) failed to deliver
Settlement: 20260413, Price: $116.40, FTD Value: $993,823.2, GLAUKOS CORP COM STK (DE)
Feb 20, 2026
Clinical Trial
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia
Phase Phase 3 — TERMINATED
Feb 9, 2026
short_interest
FTD: GKOS — 13,055 shares ($1.5M) failed to deliver
Settlement: 20260209, Price: $112.52, FTD Value: $1,468,948.6, GLAUKOS CORP COM STK (DE)
Feb 6, 2026
short_interest
FTD: GKOS — 15,911 shares ($1.8M) failed to deliver
Settlement: 20260206, Price: $113.52, FTD Value: $1,806,216.72, GLAUKOS CORP COM STK (DE)